secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001213900-25-012891
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics regains Nasdaq minimum bid price compliance, moves to Capital Market
--------------------------------------------------------------------------------

- Received Nasdaq confirmation of compliance with Bid Price Requirement on Feb 12, 2025.
- Common stock transferred to Nasdaq Capital Market per Nasdaq Panel's extension conditions.
- Extension granted until April 22, 2025; company working toward remaining conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025012891/0001213900-25-012891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025012891/ea0230890-8k_cerotherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-012891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer